COVA trial: success for the investigational agent sarconeos in hospitalised COVID-19 Presented ByDr Girish Balachandran Nair, Beaumont Hospital, MI, USA TrialPhase 3, COVA ConferenceATS 2023 31 May, 2023 08:38
Excellent results for C21 in idiopathic pulmonary fibrosis Presented ByDr Rohit Batta, Vicore Pharma, Sweden TrialPhase 2, AIR ConferenceATS 2023 25 May, 2023 11:10
COVA trial: success for the investigational agent sarconeos in hospitalised COVID-19 Presented ByDr Girish Balachandran Nair, Beaumont Hospital, MI, USA TrialPhase 3, COVA ConferenceATS 2023 31 May, 2023 08:38
Efficient detection of AECOPD with at-home vital signs monitoring Presented ByMr Yann Le Guillou, Biosency, France ConferenceATS 2023 31 May, 2023 08:36
Improving quality in sepsis through machine learning models Presented ByDr Elizabeth Munroe, University of Michigan, MI, USA ConferenceATS 2023 31 May, 2023 08:34
Mitochondrial DNA predicts COVID-19 severity Presented ByDr Marlene Cano, Washington University in Saint Louis, MO, USA ConferenceATS 2023 31 May, 2023 08:32
Can information technology improve guideline adherence in sepsis care? Presented ByDr Daniel Leisman, Massachusetts General Hospital, MA, USA ConferenceATS 2023 31 May, 2023 08:30
Practice-changing results for ensifentrine in COPD Presented ByProf. Antonio Anzueto, University of Texas Health San Antonio, TX, USA TrialPhase 3, ENHANCE-1; ENHANCE-2 ConferenceATS 2023 30 May, 2023 11:43
Alvelestat for AATD meets primary endpoints in phase 2 trial Presented ByProf. Robert Stockley, University Hospital Birmingham, UK TrialPhase 2, ASTRAEUS ConferenceATS 2023 30 May, 2023 11:42
Fewer exacerbations with dupilumab in COPD with type 2 inflammation Presented ByProf. Klaus Rabe, LungenClinic Grosshansdorf GmbH, Germany TrialPhase 3, BOREAS ConferenceATS 2023 30 May, 2023 11:40
New AATD therapy may alleviate treatment burden for patients Presented ByDr Brooks Kuhn, UC Davis School of Medicine, CA, USA ConferenceATS 2023 30 May, 2023 11:39
Remarkable results for novel camel-derived therapy for asthma Presented ByDr Benjamin Suratt, Sanofi, NJ, USA ConferenceATS 2023 30 May, 2023 11:38
Excellent results for C21 in idiopathic pulmonary fibrosis Presented ByDr Rohit Batta, Vicore Pharma, Sweden TrialPhase 2, AIR ConferenceATS 2023 25 May, 2023 11:10
May camlipixant improve quality of life of patients with refractory chronic cough? Presented ByDr Lorcan McGarvey, Queen’s University Belfast, UK TrialPhase 2, SOOTHE ConferenceATS 2023 25 May, 2023 11:09
Success for fluticasone furoate plus vilanterol in uncontrolled asthma Presented ByDr Philippe Bareille, GSK, UK ConferenceATS 2023 25 May, 2023 11:08
TORREY trial: seralutinib associated with reduced pulmonary vascular resistance in PAH Presented ByProf. Robert Frantz, Mayo Clinic, MN, USA TrialPhase 2, TORREY ConferenceATS 2023 25 May, 2023 11:07
Vitamin D for asthma protection: what is the optimal timing? Presented ByDr Lourdes Ramirez, Brigham and Women’s hospital, MA, USA ConferenceATS 2023 25 May, 2023 11:05